Page 48 - MDJ 2022 Jan-Jun, Volume 45 Number 1

Masood / Rizwan / Rizwan / Mujtaba / Farooqi / Zaib / Butt

liners or healthcare workers. Around 84 % of the antibody test, and a few participants were unsure about
participants (n = 42) were diagnosed with COVID-19 less which test was used for their diagnosis.
than 3 months ago.
86 % of the participants were COVID-19
Over our study period, the COVID-19 status of negative while 14 % were COVID-19 positive during our
86 % (n = 43) of the participants was negative while 14 % study (Figures 3 and 4).
(n = 7) were still infected with the virus.
Gender
10%
12%

25 25
78%

Male Female PCR Antibody Not sure

Figure 1: The gender distribution among the participants. Figure 3: The tests conducted for the confirmation of
COVID-19 infection.
Age

38.5 % of the participants belonged to the age
group of 31–45 years, 34 % belonged to the age group of 84%
15–30 years, 24 % belonged to the age group of 46–60
years, and only 4 % were older than 60 years of age (Figure
2).

10% 6%
38%
34%
24% < 1 month < 3 months < 6 months

Figure 4: The time at which the infection was diagnosed
4%
among the participants.
15–30 31–45 46–60 > 60 Related Medical History and Administration of BCG
years years years years
Regarding previous medical history, 72 % of the
participants had no related medical history, 12 % had
Figure 2: The age groups of the participants. allergies and hypertension, while 2 % of the participants
had diabetes and pneumonia. 78 % of the participants had
Occupation the BCG vaccine administered in their childhood, 8 % had
not received the BCG vaccine, and 14 % were not sure if
By occupation, 20 % of the participants were they had received the vaccine or not.
healthcare professionals, 78 % belonged to varied fields,
and 2 % were retired. Symptoms
Diagnosis Period and Tests Conducted The symptoms were divided into three categories
as standardised by the WHO:
84 % of the participants were diagnosed less than
3 months prior to the start of this study, 10 % were 1. Less Common Symptoms
diagnosed less than a month prior, and 6 % were diagnosed
less than 6 months before the start. Less common symptoms include sore throat,
headache, loss of taste and/or smell, aches and pains,
To confirm their diagnosis, the majority of the conjunctivitis, a rash on skin or discoloration on fingers or
participants used a PCR, some of the participants used an toes, and diarrhoea. 39 participants (78 %) who were
vaccinated faced the less common symptoms while 4

47